Related Articles
Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival
KRAS mutations in patients with colorectal cancer in Libya
Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation
The prognostic value of KRAS mutations in patients with colorectal cancer